Bentsur Ron

Bentsur Ron is listed in filings as Chairman & CEO at Nuvectis Pharma, Inc.. This profile follows SEC Form 4 activity through Jan 9, 2026, including purchase activity. Recent filings connect the profile to Nuvectis Pharma, Inc. (NVCT). The current snapshot covers public activity from Nov 18, 2024 to Jan 9, 2026. Reported amounts are shown as $28.6K to $98.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.